0

Close
 
Upcoming Allied Market Research
2023
Cannula Market

Cannula Market: Global Opportunity Analysis and Industry Forecast, 2023-2030 Market

LS : Medical Devices & Supplies
Report Code: A07071
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Cannula Market

Request Now !

A Cannula is a thin tube or hose that can be inserted in a cavity or duct in the body. It is used to drain out a fluid or introduce a new substance in the body for medicinal purpose. The cannula is available in various sizes such as 24 gauge that is used for Chemotherapy and neonates and 14 gauge used for trauma type environment that can administer 1 liter of fluid in 2 minutes. 20 Gauge Cannula is used on a day-to-day basis for fluid antibiotics. Cannula is inserted through three ways, which are peripheral, central line and midline.

Cannula

There are different types of cannulas such as cardiac cannulas, dermatology cannulas, nasal cannulas, and intravenous cannulas. Cannula is placed inside a vein to provide venous access; this process is called intravenous cannulation. Cannula is also used for nasal, oral as well as veterinary purposes. It is also used for blood transfusion, drug transfusion and chemotherapy. Cannula is used in various surgeries such as cardiovascular surgery, plastic surgery, orthopedic surgery, general surgery, diabetic treatments and others.

COVID-19 scenario analysis: 

To take care of infected population the demand for medical supplies is increasing. Monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With rise in number of COVID-19 cases worldwide, the need for medical supplies keeps on rising among, both from healthcare professionals and civil population for precautionary measures. Manufacturers of these products have a chance to capitalize this increased demand of medical supplies to ensure adequate and continuous supply of personal protective equipment in the market.

Owing to such factors, COVID-19 is expected to have a significant impact on the cannula market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The development of the cannula market is majorly effected by changes in the Government policies and funding provided by the Government for the betterment of the healthcare sector. This has resulted in the enhancement of health facilities. It is also evident that there has been increase in the number of patients going for surgical procedures in the past few years, the perception of the patients is changing toward the surgeries and they are ready to accept as the risk in the surgeries is decreasing and lifestyle-related diseases, which has fuelled the demand for cannula. Upgrading technology, introduction of new single use cannula which is mostly used in surgeries now is helping the growth of the cannula market. On the other hand, there is variation seen in the market for the demand of cannula, which is positively impacting the growth of the cannula market. If there is any mistake during the application of cannula on the person’s skin, it can lead to injuries and heavy blood loss and this has led to some protest by the end-users for ensuring safer usage of cannula. Patients also had some complaints with infection in the area where the cannula was inserted. These are the factors hampering the growth of the cannula market. .

New product launches to flourish the market:

Smith & Nephew has launched two new cannula systems Clear- TRAC Complete and Clear- TRAC Flexible. ProtekDuo cannula has been introduced by LivaNova to address Corona Virus as per the U.S.FDA indications.

Surge in usage in hospital applications:

Cannulas are used in various healthcare facilities such as hospitals, ASGs, clinics, blood banks, pathology labs, and others. According to the World Health Organization, about 234.2 million surgeries are performed every year. At an average, around 1 million patients go through cardiac surgeries and around 18 million people opt for plastic surgery annually. This shows that the hospitals are the biggest end-users for cannulas in the market. .

Various Health care providers are also trying to increase their capacity for patients, which will lead to an increase in demand for Cannula.

Key benefits of the report:

  • This study presents the analytical depiction of the global cannula industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global cannula market share.
  • The current market is quantitatively analyzed to highlight the cannula market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. The report provides a detailed global cannula market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Cannula Market research report:

  • Who are the leading market players active in the cannula market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

 Cannula Market: Global Opportunity Analysis and Industry Forecast, 2020-2027 Report Highlights

Aspects Details
By Product
  • Nasal Cannula
  • Vascular Cannula
  • Venous Cannula
  • Cardiac Cannula
  • Arthroscopy Cannula
  • Intravenous Cannula
  • Dermatology Cannula
  • Others
By Application
  • Orthopedics Surgery
  • General Surgery
  • Cardiovascular Surgery
  • Plastic Surgery
  • Oxygen Therapy
  • Others
By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Edwards Life sciences Corporation, McKesson Medical-Surgical Inc., Smiths Medical, Terumo Cardiovascular System Corporation, Smith & Nephew, LivaNova PLC, CONMED Corporation, Medtronic, Denex International, ISPG Inc.
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: CANNULA MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Nasal Cannula

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Vascular Cannula

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Venous Cannula

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Cardiac Cannula

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Arthroscopy Cannula

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. Intravenous Cannula

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

    • 4.8. Dermatology Cannula

      • 4.8.1. Key Market Trends, Growth Factors and Opportunities

      • 4.8.2. Market Size and Forecast, By Region

      • 4.8.3. Market Share Analysis, By Country

    • 4.9. Others

      • 4.9.1. Key Market Trends, Growth Factors and Opportunities

      • 4.9.2. Market Size and Forecast, By Region

      • 4.9.3. Market Share Analysis, By Country

  • CHAPTER 5: CANNULA MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Orthopedics Surgery

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. General Surgery

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Cardiovascular Surgery

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Plastic Surgery

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Oxygen Therapy

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Others

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

  • CHAPTER 6: CANNULA MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Clinics

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Ambulatory Surgery Centers

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Others

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

  • CHAPTER 7: CANNULA MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Cannula Market

        • 7.2.6.1. Market Size and Forecast, By Product
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By End User

      • 7.2.7. Canada Cannula Market

        • 7.2.7.1. Market Size and Forecast, By Product
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By End User

      • 7.2.8. Mexico Cannula Market

        • 7.2.8.1. Market Size and Forecast, By Product
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By End User

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Cannula Market

        • 7.3.6.1. Market Size and Forecast, By Product
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By End User

      • 7.3.7. Germany Cannula Market

        • 7.3.7.1. Market Size and Forecast, By Product
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By End User

      • 7.3.8. Italy Cannula Market

        • 7.3.8.1. Market Size and Forecast, By Product
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By End User

      • 7.3.9. Spain Cannula Market

        • 7.3.9.1. Market Size and Forecast, By Product
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By End User

      • 7.3.10. UK Cannula Market

        • 7.3.10.1. Market Size and Forecast, By Product
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By End User

      • 7.3.11. Russia Cannula Market

        • 7.3.11.1. Market Size and Forecast, By Product
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By End User

      • 7.3.12. Rest Of Europe Cannula Market

        • 7.3.12.1. Market Size and Forecast, By Product
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By End User

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Cannula Market

        • 7.4.6.1. Market Size and Forecast, By Product
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By End User

      • 7.4.7. Japan Cannula Market

        • 7.4.7.1. Market Size and Forecast, By Product
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By End User

      • 7.4.8. India Cannula Market

        • 7.4.8.1. Market Size and Forecast, By Product
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By End User

      • 7.4.9. South Korea Cannula Market

        • 7.4.9.1. Market Size and Forecast, By Product
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By End User

      • 7.4.10. Australia Cannula Market

        • 7.4.10.1. Market Size and Forecast, By Product
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By End User

      • 7.4.11. Thailand Cannula Market

        • 7.4.11.1. Market Size and Forecast, By Product
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By End User

      • 7.4.12. Malaysia Cannula Market

        • 7.4.12.1. Market Size and Forecast, By Product
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By End User

      • 7.4.13. Indonesia Cannula Market

        • 7.4.13.1. Market Size and Forecast, By Product
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By End User

      • 7.4.14. Rest of Asia Pacific Cannula Market

        • 7.4.14.1. Market Size and Forecast, By Product
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By End User

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Cannula Market

        • 7.5.6.1. Market Size and Forecast, By Product
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By End User

      • 7.5.7. South Africa Cannula Market

        • 7.5.7.1. Market Size and Forecast, By Product
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By End User

      • 7.5.8. Saudi Arabia Cannula Market

        • 7.5.8.1. Market Size and Forecast, By Product
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By End User

      • 7.5.9. UAE Cannula Market

        • 7.5.9.1. Market Size and Forecast, By Product
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By End User

      • 7.5.10. Argentina Cannula Market

        • 7.5.10.1. Market Size and Forecast, By Product
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By End User

      • 7.5.11. Rest of LAMEA Cannula Market

        • 7.5.11.1. Market Size and Forecast, By Product
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By End User

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Medtronic

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Smith And Nephew

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Edwards Life Sciences Corporation

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Terumo Cardiovascular System Corporation

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. LivaNova PLC

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. CONMED Corporation

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. McKesson Medical-Surgical Inc.

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. ISPG Inc.

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Denex International

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Smiths Medical

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL CANNULA MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL CANNULA MARKET FOR NASAL CANNULA, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL CANNULA MARKET FOR VASCULAR CANNULA, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL CANNULA MARKET FOR VENOUS CANNULA, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL CANNULA MARKET FOR CARDIAC CANNULA, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL CANNULA MARKET FOR ARTHROSCOPY CANNULA, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL CANNULA MARKET FOR INTRAVENOUS CANNULA, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL CANNULA MARKET FOR DERMATOLOGY CANNULA, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL CANNULA MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL CANNULA MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL CANNULA MARKET FOR ORTHOPEDICS SURGERY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL CANNULA MARKET FOR GENERAL SURGERY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL CANNULA MARKET FOR CARDIOVASCULAR SURGERY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL CANNULA MARKET FOR PLASTIC SURGERY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL CANNULA MARKET FOR OXYGEN THERAPY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL CANNULA MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL CANNULA MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL CANNULA MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL CANNULA MARKET FOR CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. GLOBAL CANNULA MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. GLOBAL CANNULA MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. GLOBAL CANNULA MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA CANNULA, BY REGION, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 26. NORTH AMERICA CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. U.S. CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 28. U.S. CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. U.S. CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. CANADA CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 31. CANADA CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. CANADA CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. MEXICO CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 34. MEXICO CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. MEXICO CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. EUROPE CANNULA, BY REGION, 2022-2032 ($MILLION)
  • TABLE 37. EUROPE CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. EUROPE CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. FRANCE CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 41. FRANCE CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. FRANCE CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. GERMANY CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 44. GERMANY CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. GERMANY CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. ITALY CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 47. ITALY CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. ITALY CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. SPAIN CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 50. SPAIN CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 51. SPAIN CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. UK CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 53. UK CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 54. UK CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. RUSSIA CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 56. RUSSIA CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. RUSSIA CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 58. REST OF EUROPE CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 59. REST OF EUROPE CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 60. REST OF EUROPE CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. ASIA-PACIFIC CANNULA, BY REGION, 2022-2032 ($MILLION)
  • TABLE 62. ASIA-PACIFIC CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 63. ASIA-PACIFIC CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 64. ASIA-PACIFIC CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. CHINA CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 66. CHINA CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 67. CHINA CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. JAPAN CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 69. JAPAN CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. JAPAN CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. INDIA CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 72. INDIA CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 73. INDIA CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. SOUTH KOREA CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 75. SOUTH KOREA CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 76. SOUTH KOREA CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 77. AUSTRALIA CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 78. AUSTRALIA CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 79. AUSTRALIA CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. THAILAND CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 81. THAILAND CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 82. THAILAND CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 83. MALAYSIA CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 84. MALAYSIA CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 85. MALAYSIA CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 86. INDONESIA CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 87. INDONESIA CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 88. INDONESIA CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 89. REST OF ASIA PACIFIC CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 90. REST OF ASIA PACIFIC CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 91. REST OF ASIA PACIFIC CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 92. LAMEA CANNULA, BY REGION, 2022-2032 ($MILLION)
  • TABLE 93. LAMEA CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 94. LAMEA CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 95. LAMEA CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 96. BRAZIL CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 97. BRAZIL CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 98. BRAZIL CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 99. SOUTH AFRICA CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 100. SOUTH AFRICA CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 101. SOUTH AFRICA CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 102. SAUDI ARABIA CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 103. SAUDI ARABIA CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 104. SAUDI ARABIA CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 105. UAE CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 106. UAE CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 107. UAE CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 108. ARGENTINA CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 109. ARGENTINA CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 110. ARGENTINA CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 111. REST OF LAMEA CANNULA, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 112. REST OF LAMEA CANNULA, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 113. REST OF LAMEA CANNULA, BY END USER, 2022-2032 ($MILLION)
  • TABLE 114. MEDTRONIC: KEY EXECUTIVES
  • TABLE 115. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 116. MEDTRONIC: OPERATING SEGMENTS
  • TABLE 117. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 118. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. SMITH AND NEPHEW: KEY EXECUTIVES
  • TABLE 120. SMITH AND NEPHEW: COMPANY SNAPSHOT
  • TABLE 121. SMITH AND NEPHEW: OPERATING SEGMENTS
  • TABLE 122. SMITH AND NEPHEW: PRODUCT PORTFOLIO
  • TABLE 123. SMITH AND NEPHEW: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 124. EDWARDS LIFE SCIENCES CORPORATION: KEY EXECUTIVES
  • TABLE 125. EDWARDS LIFE SCIENCES CORPORATION: COMPANY SNAPSHOT
  • TABLE 126. EDWARDS LIFE SCIENCES CORPORATION: OPERATING SEGMENTS
  • TABLE 127. EDWARDS LIFE SCIENCES CORPORATION: PRODUCT PORTFOLIO
  • TABLE 128. EDWARDS LIFE SCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 129. TERUMO CARDIOVASCULAR SYSTEM CORPORATION: KEY EXECUTIVES
  • TABLE 130. TERUMO CARDIOVASCULAR SYSTEM CORPORATION: COMPANY SNAPSHOT
  • TABLE 131. TERUMO CARDIOVASCULAR SYSTEM CORPORATION: OPERATING SEGMENTS
  • TABLE 132. TERUMO CARDIOVASCULAR SYSTEM CORPORATION: PRODUCT PORTFOLIO
  • TABLE 133. TERUMO CARDIOVASCULAR SYSTEM CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 134. LIVANOVA PLC: KEY EXECUTIVES
  • TABLE 135. LIVANOVA PLC: COMPANY SNAPSHOT
  • TABLE 136. LIVANOVA PLC: OPERATING SEGMENTS
  • TABLE 137. LIVANOVA PLC: PRODUCT PORTFOLIO
  • TABLE 138. LIVANOVA PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 139. CONMED CORPORATION: KEY EXECUTIVES
  • TABLE 140. CONMED CORPORATION: COMPANY SNAPSHOT
  • TABLE 141. CONMED CORPORATION: OPERATING SEGMENTS
  • TABLE 142. CONMED CORPORATION: PRODUCT PORTFOLIO
  • TABLE 143. CONMED CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 144. MCKESSON MEDICAL-SURGICAL INC.: KEY EXECUTIVES
  • TABLE 145. MCKESSON MEDICAL-SURGICAL INC.: COMPANY SNAPSHOT
  • TABLE 146. MCKESSON MEDICAL-SURGICAL INC.: OPERATING SEGMENTS
  • TABLE 147. MCKESSON MEDICAL-SURGICAL INC.: PRODUCT PORTFOLIO
  • TABLE 148. MCKESSON MEDICAL-SURGICAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149. ISPG INC.: KEY EXECUTIVES
  • TABLE 150. ISPG INC.: COMPANY SNAPSHOT
  • TABLE 151. ISPG INC.: OPERATING SEGMENTS
  • TABLE 152. ISPG INC.: PRODUCT PORTFOLIO
  • TABLE 153. ISPG INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 154. DENEX INTERNATIONAL: KEY EXECUTIVES
  • TABLE 155. DENEX INTERNATIONAL: COMPANY SNAPSHOT
  • TABLE 156. DENEX INTERNATIONAL: OPERATING SEGMENTS
  • TABLE 157. DENEX INTERNATIONAL: PRODUCT PORTFOLIO
  • TABLE 158. DENEX INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 159. SMITHS MEDICAL: KEY EXECUTIVES
  • TABLE 160. SMITHS MEDICAL: COMPANY SNAPSHOT
  • TABLE 161. SMITHS MEDICAL: OPERATING SEGMENTS
  • TABLE 162. SMITHS MEDICAL: PRODUCT PORTFOLIO
  • TABLE 163. SMITHS MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL CANNULA MARKET SEGMENTATION
  • FIGURE 2. GLOBAL CANNULA MARKET
  • FIGURE 3. SEGMENTATION CANNULA MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN CANNULA MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCANNULA MARKET
  • FIGURE 11. CANNULA MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. CANNULA MARKET FOR NASAL CANNULA, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. CANNULA MARKET FOR VASCULAR CANNULA, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. CANNULA MARKET FOR VENOUS CANNULA, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. CANNULA MARKET FOR CARDIAC CANNULA, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. CANNULA MARKET FOR ARTHROSCOPY CANNULA, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. CANNULA MARKET FOR INTRAVENOUS CANNULA, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. CANNULA MARKET FOR DERMATOLOGY CANNULA, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. CANNULA MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. CANNULA MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 21. CANNULA MARKET FOR ORTHOPEDICS SURGERY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. CANNULA MARKET FOR GENERAL SURGERY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. CANNULA MARKET FOR CARDIOVASCULAR SURGERY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. CANNULA MARKET FOR PLASTIC SURGERY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. CANNULA MARKET FOR OXYGEN THERAPY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. CANNULA MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 27. CANNULA MARKET SEGMENTATION, BY BY END USER
  • FIGURE 28. CANNULA MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 29. CANNULA MARKET FOR CLINICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 30. CANNULA MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 31. CANNULA MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 32. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 33. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 34. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 35. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 36. COMPETITIVE DASHBOARD
  • FIGURE 37. COMPETITIVE HEATMAP: CANNULA MARKET
  • FIGURE 38. Top player positioning, 2022
  • FIGURE 39. MEDTRONIC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. MEDTRONIC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. SMITH AND NEPHEW: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. SMITH AND NEPHEW: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. SMITH AND NEPHEW: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. EDWARDS LIFE SCIENCES CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. EDWARDS LIFE SCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. EDWARDS LIFE SCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. TERUMO CARDIOVASCULAR SYSTEM CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. TERUMO CARDIOVASCULAR SYSTEM CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. TERUMO CARDIOVASCULAR SYSTEM CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. LIVANOVA PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. LIVANOVA PLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. LIVANOVA PLC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. CONMED CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. CONMED CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. CONMED CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. MCKESSON MEDICAL-SURGICAL INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. MCKESSON MEDICAL-SURGICAL INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. MCKESSON MEDICAL-SURGICAL INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 60. ISPG INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. ISPG INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 62. ISPG INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 63. DENEX INTERNATIONAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 64. DENEX INTERNATIONAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 65. DENEX INTERNATIONAL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 66. SMITHS MEDICAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 67. SMITHS MEDICAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 68. SMITHS MEDICAL: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Cannula Market

Start reading.
This Report and over 68,439+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers